Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer

ClinicalTrials.gov ID: NCT00069121

Public ClinicalTrials.gov record NCT00069121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) ("XELOX") Versus Fluorouracil/Leucovorin as Adjuvant Therapy for Patients Who Have Undergone Surgery for Colon Carcinoma, AJCC/UICC Stage III (Dukes Stage C)

Study identification

NCT ID
NCT00069121
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,886 participants

Conditions and interventions

Interventions

  • Capecitabine Drug
  • Oxaliplatin Drug
  • Leucovorin (LV) Drug
  • 5-Fluorouracil (5-FU) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 17, 2003
Primary completion
Apr 20, 2011
Completion
Apr 20, 2011
Last update posted
Mar 5, 2020

2003 – 2011

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
The Cancer Center At Providence Park Mobile Alabama 36608
Central Hematology Oncology Medical Group Inc. Alhambra California 91801
Comprehensive Blood/Cancer Ctr Bakersfield California 93309
Virginia K. Crossen Cancer Center Fullerton California 92835
Pacific Shores Medical Group Long Beach California 90813
West Valley Hematology Oncology The Thomas and Dorothy Leavey Cancer Center Northridge California 91325
Ventura County Hematology-Oncology Specialists Oxnard California 93030
Wilshire Oncology Medical Group Pomona California 91767
Sutter Cancer Center Sacramento California 95816
Scripps Cancer Center San Diego California 92121
Kaiser Permanente San Diego; Hepatology Research San Diego California 92154
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105
San Diego Cancer Center'S Medical Group Vista California 92083
Innovative clinical research institute/American institute of research Whittier California 90603
University of Colorado Health Science Center; Biomedical Research Bldg. Room 511 Aurora Colorado 80045
Hematology Oncology Associates Fort Collins Colorado 80528
Hematology Oncology P.C. Stamford Connecticut 06902
Georgetown Uni Medical Center; Lombardi Cancer Center Washington D.C. District of Columbia 20007
Lakeland Regional Cancer Center Lakeland Florida 33804-1057
Uni of Miami School of Medicine; Sylvester Comprehensive Cancer Center Miami Florida 33136
Georgia Cancer Specialists Atlanta Georgia 30341
Illinois Cancer Care Peoria Illinois 61615
Hope Center Terre Haute Indiana 47802
Ochsner Cancer Inst. New Orleans Louisiana 70121
Park Nicollet Clinic Cancer Center Saint Louis Park Minnesota 55416
St Joseph Oncology Saint Joseph Missouri 64507
Hematology Oncology Consultants, Inc. St Louis Missouri 63136
Hematology-Oncology Centers of the Northern Rockies Billings Montana 59101
Great Falls Clinic Great Falls Montana 59405
Va Medical Center Reno Nevada 89502
Nh Oncology Hematology, Pa Hooksett New Hampshire 03106
Morristown Medical Center;Hematology-Oncology Assoc Morristown New Jersey 07962
Overlook Oncology Center; Summit Medical Group Summit New Jersey 07901
New Mexico Oncology Hematology Consultants Albuquerque New Mexico 87109
St. Vincent'S Hospital; Comprehensive Care Center New York New York 10011
Presbyterian Healthcare; Cancer Research Dept Charlotte North Carolina 28233-3549
Moses Cone Reg Cancer Ctr Greensboro North Carolina 27403
Carolina Oncology Specialists, PA - Hickory Hickory North Carolina 28602
Oncology-Hematology of Lehigh Valley, Pc Bethlehem Pennsylvania 18015
Medical Oncology Associates Kingston Pennsylvania 18704
Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology Philadelphia Pennsylvania 19104-4283
Fox Chase-Temple Cancer Center Philadelphia Pennsylvania 19111
Uni of Pittsburgh Cancer Inst. ; Oncology Pittsburgh Pennsylvania 15232
West Clinic Germantown Tennessee 38138
US Oncology The Woodlands Texas 77380
Intermountain Hematology & Oncology Salt Lake City Utah 84106
Internal Medicine Associates of Yakima Inc. Yakima Washington 98902
UNI OF WISCONSIN SCHOOL OF MEDICINE; GI Oncology Research Group, Paul P Carbone Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 184 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00069121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00069121 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →